The neurosurgeons of Weill Cornell Medicine are universally recognized as premier providers of minimally invasive surgical procedures for the brain and spine in both adult and pediatric patients. Leaders in high-tech, computerized diagnosis and treatment methods, our specialists receive patients from around the world and treat the full spectrum of neurological disease, from brain and spine tumors, stroke, aneurysm and epilepsy to Parkinson's disease and other movement disorders.
At the forefront of emerging technology, our facilities offer Gamma Knife procedures, stereotactic radiosurgery, frameless stereotaxy, endoscopic surgery and three-dimensional visualization in the operating room. The success of our minimal-access surgical procedures is frequently reported by a wide variety of media outlets, with recent articles documenting our use of spinal surgery to prevent paralysis, as well as removal of giant brain tumors through the nasal cavity. Our clinical services also continue after surgery, with on-staff neuropsychologists who offer testing and treatment for emotional and cognitive issues that may arise. Our Clinical Services
Training the Next Generation
As educators, our staff members teach medical students, residents and fellows, both nationally and abroad. They also design and present specialized continuing medical education courses and other training courses regarding skull base surgery, endonasal surgery, cutting-edge pediatric surgery and minimally invasive approaches to spinal surgery. We provide monthly Grand Rounds lectures and are also proud to host the annual SNS Junior Resident Training Day, where those completing their internship year learn the fundamental skills of neurosurgery.
As treatments for neurological diseases of the brain and spine rapidly evolve and advance, our neurologists serve as world leaders in the implementation of these new treatment paradigms. Education
Pioneers in Research and Clinical Trials
In addition to their clinical work, our neurosurgeons actively pursue new frontiers in research. Their advancements include the first gene therapy treatment for Parkinson's, successful isolation of human stem cells from both normal and tumorous human brains, computer mapping of the brain in order to cure epilepsy through surgery, and a cutting-edge approach to pediatric hydrocephalus (water on the brain) treatment that eliminates the need for shunts and spares children from unnecessary infections. Research
Bridging the distance from lab bench to patient bedside, we also feature active clinical trials for stroke, aneurysm, spinal fusion and resistant brain tumor patients. Clinical Trials